Piotr P. Witkowski to Immunosuppressive Agents
This is a "connection" page, showing publications Piotr P. Witkowski has written about Immunosuppressive Agents.
Connection Strength
0.858
-
Post-Hoc Analysis of a Randomized, Double Blind, Prospective Study at the University of Chicago: Additional Standardizations of Trial Protocol are Needed to Evaluate the Effect of a CXCR1/2 Inhibitor in Islet Allotransplantation. Cell Transplant. 2021 Jan-Dec; 30:9636897211001774.
Score: 0.530
-
Coating human pancreatic islets with CD4(+)CD25(high)CD127(-) regulatory T cells as a novel approach for the local immunoprotection. Ann Surg. 2011 Sep; 254(3):512-8; discussion 518-9.
Score: 0.277
-
Targeting CXCR1/2 Does Not Improve Insulin Secretion After Pancreatic Islet Transplantation: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Type 1 Diabetes. Diabetes Care. 2020 04; 43(4):710-718.
Score: 0.031
-
Enhancing pancreatic Beta-cell regeneration in vivo with pioglitazone and alogliptin. PLoS One. 2013; 8(6):e65777.
Score: 0.020